Drug Trial Radar · NCT00000991
A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients
Last checked: Nov 19, 2026Latest source record: Nov 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
600
Actual
Start
Not stated
Primary completion
Not stated
Study completion Apr 1994
Sponsor
- Sponsor type
- NIH
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate and compare 3 anti-pneumocystis regimens plus zidovudine (AZT) in persons with HIV infection and T4 cell count less than 200 cells/mm3. All persons completing at least 8 weeks of therapy on 081 will be offered the opportunity to participate in the nested study (ACTG 981) of systemic antifungal therapy (fluconazole) versus local therapy (Clotrimazole) for the prevention of serious fungal disease. Persons with HIV disease who are receiving AZT are at risk for PCP, toxoplasmosis, bacterial pneumonia, and other serious infections. It is therefore important to find drugs that can be given along with AZT to control these infections. Aerosolized pentamidine (PEN) has been shown to be useful in preventing PCP and is expected to lower the 2-year risk of PCP. Both sulfamethoxazole/trimethoprim (SMX/TMP) and dapsone probably also provide effective preventive treatment against PCP, and both may be useful in preventing toxoplasmosis and extrapulmonary pneumocystosis.
Conditions
- Pneumonia, Pneumocystis Carinii
- HIV Infections
Interventions
Pentamidine isethionateDrug
Sulfamethoxazole-TrimethoprimDrug
DapsoneDrug
ZidovudineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
21 sites in 2 countries. Site status is shown where the registry gives one.
USC CRS
Los Angeles, California
Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.
Oakland, California
Ucsd, Avrc Crs
San Diego, California
Univ. of Miami AIDS CRS
Miami, Florida
Chicago Children's CRS
Chicago, Illinois
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
Indianapolis, Indiana
Johns Hopkins Adult AIDS CRS
Baltimore, Maryland
Massachusetts General Hospital ACTG CRS
Boston, Massachusetts
Beth Israel Deaconess - East Campus A0102 CRS
Boston, Massachusetts
Beth Israel Deaconess Med. Ctr., ACTG CRS
Boston, Massachusetts
University of Minnesota, ACTU
Minneapolis, Minnesota
Washington U CRS
St Louis, Missouri
SUNY - Buffalo, Erie County Medical Ctr.
Buffalo, New York
Univ. of Rochester ACTG CRS
Rochester, New York
Unc Aids Crs
Chapel Hill, North Carolina
Duke Univ. Med. Ctr. Adult CRS
Durham, North Carolina
Case CRS
Cleveland, Ohio
The Ohio State Univ. AIDS CRS
Columbus, Ohio
Pitt CRS
Pittsburgh, Pennsylvania
University of Washington AIDS CRS
Seattle, Washington
Mbeya Med. Research Program, Mbeya Referral Hosp. CRS
Mbeya, Tanzania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.